Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Infection and Immunity

• Publication date

  1993-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/iai.61.12.5271-5278.1993PMID 7693598PMCID PMC281311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Internalization in vivo of cholera toxin in the small intestinal epithelium of the rat.

  2009cited by this paper
• Role of membrane gangliosides in the binding and action of bacterial toxins

  2005cited by this paper
• Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo

  1993cited by this paper
• Vaccines against enteric infections.

  1992cited by this paper
• Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: role of vesicular traffic

  1992cited by this paper
• Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium

  1992cited by this paper
• Host defense against cholera toxin is strongly CD4+ T cell dependent

  1991cited by this paper
• New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection

  1991cited by this paper
• Modern vaccines. Enteric infections.

  1990cited by this paper
• Study of epitopes of cholera enterotoxin-related enterotoxins by checkerboard immunoblotting

  1990cited by this paper
• Established intestinal cell lines as model systems for electrolyte transport studies.

  1990cited by this paper
• Characterization of the Vibrio cholerae ToxR Regulon: Identification of Novel Genes Involved in Intestinal Colonization

  1989cited by this paper
• Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge.

  1989cited by this paper
• Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins

  1989cited by this paper
• Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques

  1988cited by this paper
• Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans

  1988cited by this paper
• The antisecretory factors: inducible proteins which modulate secretion in the small intestine.

  1988cited by this paper
• Long‐Term Cholera Antitoxin Memory in the Gut can be Triggered to Antibody Formation Associated with Protection within Hours of an Oral Challenge Immunization

  1987cited by this paper
• Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein.

  1987cited by this paper
• Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.

  1987cited by this paper
• Epitopes of the cholera family of enterotoxins.

  1987cited by this paper
• Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease

  1986cited by this paper
• IgA antibodies in rat bile inhibit cholera toxin-induced secretion in ileal loops in situ.

  1985cited by this paper
• Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

  1984cited by this paper
• Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.

  1984cited by this paper
• Protection against experimental cholera in the rat. A study on the formation of antibodies against cholera toxin and desensitization of adenylate cyclase after immunization with cholera toxin.

  1984cited by this paper
• New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

  1983cited by this paper
• Antibacterial and Antitoxin Responses in the Serum and Milk of Cholera Patients

  1981cited by this paper
• Actions of cholera toxin and the prevention and treatment of cholera

  1981cited by this paper
• Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.

  1979cited by this paper
• Protection against experimental cholera by oral or parenteral immunization

  1979cited by this paper
• Genetic evidence that cholera toxin substrates are regulatory components of adenylate cyclase.

  1978cited by this paper
• ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.

  1978cited by this paper
• Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.

  1977cited by this paper
• Mechanisms of disease and immunity in cholera: a review.

  1977cited by this paper
• Immunological control mechanism against cholera toxin: interference with toxin binding to intestinal receptors

  1976cited by this paper
• Interaction of cholera toxin and membrane GM1 ganglioside of small intestine.

  1975cited by this paper
• Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.

  1974cited by this paper
• Gangliosides and membrane receptors for cholera toxin.

  1973cited by this paper
• Chemical and physical properties of cholera exo-enterotoxin (choleragen) and its spontaneously formed toxoid (choleragenoid).

  1972cited by this paper
• Pathogenesis of intestinal infections.

  1969cited by this paper

• Antibodies and Inflammation: Fecal Biomarkers of Gut Health in Domestic Ruminants

  2025cites this paper
• Leveraging Organ‐on‐Chip Models to Investigate Host–Microbiota Dynamics and Targeted Therapies for Inflammatory Bowel Disease

  2024cites this paper
• Role of cellular effectors in the induction and maintenance of IgA responses leading to protective immunity against enteric bacterial pathogens

  2024cites this paper
• Artificial parasin I protein (API) supplementation improves growth performance and intestinal health in weaned piglets challenged with enterotoxigenic Escherichiacoli

  2024cites this paper
• The role of hormones in the regulation of lactogenic immunity in porcine and bovine species.

  2024cites this paper
• Small Intestinal Goblet Cells Control Humoral Immune Responses and Mobilization During Enteric Infection

  2024cites this paper
• The therapeutic potential of dietary intervention: based on the mechanism of a tryptophan derivative-indole propionic acid on metabolic disorders

  2024cites this paper
• Characterization and utility of two monoclonal antibodies to cholera toxin B subunit

  2023cites this paper
• IgA in human health and diseases: Potential regulator of commensal microbiota

  2022cites this paper
• Role of Human Milk Bioactives on Infants' Gut and Immune Health

  2021cites this paper
• Reciprocal regulation of IgA and the gut microbiota: a key mutualism in the intestine.

  2021cites this paper
• Gut Microbiome Homeostasis and the CD4 T- Follicular Helper Cell IgA Axis in Human Immunodeficiency Virus Infection

  2021cites this paper
• Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection

  2020cites this paper
• Immune exclusion by naturally-acquired secretory IgA to the pneumococcal pilus-1.

  2020cites this paper
• Immunocomposition of Gastrointestinal Tract of Gut

  2020cites this paper
• Naturally secreted bacterial outer membrane vesicles: potential platform for a vaccine against Campylobacter jejuni

  2020cites this paper
• Altered systemic and intestinal IgA immune responses in individuals with type 1 diabetes.

  2020cites this paper
• Passive Immunity to Vibrio cholerae O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk

  2020cites this paper
• Resident Memory B Cells

  2020cites this paper
• Depletion of dietary aryl hydrocarbon receptor ligands alters microbiota composition and function

  2019cites this paper
• Differences in Maternal Immunoglobulins within Mother’s Own Breast Milk and Donor Breast Milk and across Digestion in Preterm Infants

  2019cites this paper
• Secretory IgA Enhances Gut B Cells Priming and Systemic IgG Responses Towards Commensals

  2019cites this paper
• Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system.

  2019cites this paper
• Investigation into the regulatory mechanisms of the NOD2 signalling pathway

  2018cites this paper
• Selective IgA Deficiency

  2018cites this paper
• Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination

  2018cites this paper
• Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids promote gastrointestinal colonization of Candida albicans

  2018cites this paper
• Counteracting Roles for the Related E26 Transformation Specific Transcription Factors Spi-B and Spi-C in Regulating Antibody-Forming Responses

  2018cites this paper
• The epithelial barrier and immunoglobulin A system in allergy

  2016cites this paper
• Per-Oral Immunization with Antigen-Conjugated Nanoparticles followed by Sub-Cutaneous Boosting Immunization Induces Long-Lasting Mucosal and Systemic Antibody Responses in Mice

  2015cites this paper
• Role of probiotics , prebiotics , synbiotics and postbiotics in inhibition of pathogens

  2015cites this paper
• The Regulation of IgA Production

  2015cites this paper
• IBD Candidate Genes and Intestinal Barrier Regulation

  2014cites this paper
• TTSS2-deficient hha mutant of Salmonella Typhimurium exhibits significant systemic attenuation in immunocompromised hosts

  2014cites this paper
• Construction of a Chimeric Secretory IgA and Its Neutralization Activity against Avian Influenza Virus H5N1

  2014cites this paper
• Immune response of oral cholera vaccine, Shanchol in Bangladeshi recipients

  2014cites this paper
• Microbiota activation and regulation of innate and adaptive immunity

  2014cites this paper
• Pathogenesis of Human Enterovirulent Bacteria: Lessons from Cultured, Fully Differentiated Human Colon Cancer Cell Lines

  2013cites this paper
• Grape Extracts Inhibit Multiple Events in the Cell Biology of Cholera Intoxication

  2013cites this paper
• Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces

  2013cites this paper
• Communication between B-Cells and Microbiota for the Maintenance of Intestinal Homeostasis

  2013cites this paper
• Mechanistic Insights into the Neutralization of Cytotoxic Abrin by the Monoclonal Antibody D6F10

  2013cites this paper
• The Gastrointestinal Frontier: IgA and Viruses

  2013cites this paper
• Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA.

  2011cites this paper
• Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco

  2011cites this paper
• Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut

  2011cites this paper
• Secretory IgA: Arresting Microbial Pathogens at Epithelial Borders

  2010cites this paper
• Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation

  2009cites this paper
• A Monoclonal Immunoglobulin G Antibody Directed against an Immunodominant Linear Epitope on the Ricin A Chain Confers Systemic and Mucosal Immunity to Ricin

  2009cites this paper
• Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?

  2009cites this paper
• IgA1 antibodies specific for outer membrane protein PorA modulate the interaction between Neisseria meningitidis and the epithelium.

  2009cites this paper
• Desarrollo y validación de un modelo experimental de encefalopatía hepática en ratas con ascitis. Efectos de la administración de IGF-1 frente a rifaximina en este modelo experimental

  2008cites this paper
• Affinity Chromatographic Purification of Antibodies

  2007cites this paper
• Production and Characterization of IgA Monoclonal Antibody Against Ovalbumin

  2007cites this paper
• Mucosal immunotherapy of tuberculosis: is there a value in passive IgA?

  2006cites this paper
• Immunoglobulin A Antibodies against Ricin A and B Subunits Protect Epithelial Cells from Ricin Intoxication

  2006cites this paper
• High Efficiency Cross‐Reactive Monoclonal Antibody Production by Oral Immunization with Recombinant Norwalk Virus‐Like Particles

  2006cites this paper
• Production of IgA monoclonal antibody against Shiga toxin binding subunits employing nasal-associated lymphoid tissue.

  2005cites this paper
• Polymeric composite membranes and biomimetic affinity ligands for bioseparation and immunoadsorption

  2005cites this paper
• Nervous Tissues Does Not Cause Inflammation or Accumulate Vaccine Adjuvant Administered Intranasally The Cholera Toxin-Derived CTA 1-DD

  2004cites this paper
• Secretory IgA Serve as Receptors for Ricin Oligosaccharide Side Chains on Human

  2004cites this paper
• Secretory Immunoglobulin A Antibodies against the σ1 Outer Capsid Protein of Reovirus Type 1 Lang Prevent Infection of Mouse Peyer's Patches

  2004cites this paper
• Oligosaccharide Side Chains on Human Secretory IgA Serve as Receptors for Ricin1

  2004cites this paper
• The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues1

  2004cites this paper
• Lymphoid microenvironment in the gut for immunoglobulin A and inflammation

  2003cites this paper
• Cytokines as Adjuvants for the Induction of Anti-Human Immunodeficiency Virus Peptide Immunoglobulin G (IgG) and IgA Antibodies in Serum and Mucosal Secretions after Nasal Immunization

  2002cites this paper
• Recombinant immunoglobulin A: powerful tools for fundamental and applied research.

  2002cites this paper
• Inmunoprotección por leche humana

  2002cites this paper
• Novel ligands for the affinity-chromatographic purification of antibodies.

  2001cites this paper
• Antibody-mediated protection of mucosal surfaces.

  1999cites this paper
• Mechanisms of B Cell Neoplasia 1998

  1999cites this paper
• Peritoneal B-1 cells switch in vivo to IgA and these IgA antibodies can bind to bacteria of the normal intestinal microflora.

  1999cites this paper
• Development of a bioprocess for murine dimeric IgA production

  1998cites this paper
• Efficacy of a food plant-based oral cholera toxin B subunit vaccine

  1998cites this paper
• A synthetic ligand for IgA affinity purification

  1998cites this paper
• Antigen-specific immunoglobulin-A prevents increased airway responsiveness and lung eosinophilia after airway challenge in sensitized mice.

  1998cites this paper
• Microbiology of bacterial translocation in humans

  1998cites this paper
• Distribution of Monoclonal Antibodies in Intestinal and Urogenital Secretions of Mice Bearing Hybridoma ‘Backpack’ Tumours

  1997cites this paper
• Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.

  1997cites this paper
• Antigen sampling across epithelial barriers and induction of mucosal immune responses.

  1996cites this paper
• 3 – Antigen Uptake by M Cells for Effective Mucosal Vaccines

  1996cites this paper
• Intestinal immunity to Vibrio cholerae

  1996cites this paper
• Neonatal gastrointestinal mucosal immunity.

  1996cites this paper
• Production of Human Secretory Component with Dimeric IgA Binding Capacity Using Viral Expression Systems (*)

  1995cites this paper
• Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis

  1995cites this paper
• CELLULAR MODELS IN NATURAL TOXINS INVESTIGATIONS: INTESTINAL AND KIDNEY CELL LINES

  1995cites this paper
• Altered hepatic transport of immunoglobulin A in mice lacking the J chain

  1995cites this paper
• Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces

  1994cites this paper
• Induction ofSpecific Immunoglobulin A intheSmallIntestine, Colon-Rectum, andVagina Measured bya New Methodfor Collection ofSecretions fromLocalMucosalSurfaces

  1994cites this paper
• Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium.

  1994cites this paper
• Bovine colostrum ultrafiltrate: an effective supplement for the culture of mouse-mouse hybridoma cells.

  1994cites this paper
• andAnti-Cholera ToxinImmunoglobulin A (IgA) Antibodies inProtection against Vibrio cholerae andCholera ToxinbyUse ofMonoclonal IgAAntibodies InVivo

  1993cites this paper
• Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo

  1993cites this paper
• Deficiencia selectiva de inmunoglobulina A (IgA)

  1992cites this paper
• Bacterial translocation from the gastrointestinal tract.

  1990cites this paper
• Serveur Académique Lausannois SERVAL serval.unil.ch

  year unknowncites this paper